ICU MEDICAL INC/DE - Common Stock (ICUI)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ICUI on Nasdaq
CUSIP
44930G107
Type / Class
Equity / Common Stock
Underlying class
Common Stock
Shares outstanding
24.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
25.8M
Holdings value
$3.09B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
265
Number of buys
133
Number of sells
-141
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ICU MEDICAL INC/DE - Common Stock (ICUI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% 0% $304M $253K 2.47M +0.08% JANUS HENDERSON GROUP PLC Jun 30, 2025

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 25.8M $3.09B +$75.9M $119.96 265
2025 Q2 25.1M $3.31B +$97.7M $132.15 272
2025 Q1 24.3M $3.38B +$22M $138.86 281
2024 Q4 24.2M $3.76B -$19.9M $155.17 285
2024 Q3 24.2M $4.41B +$45.5M $182.22 285
2024 Q2 23.7M $2.81B +$177M $118.75 258
2024 Q1 22.3M $2.39B +$85.3M $107.32 249
2023 Q4 515K $51.4M -$4.13M $99.74 5
2023 Q3 21.8M $2.6B -$32.8M $119.01 210
2023 Q2 22.1M $3.93B -$107M $178.19 225
2023 Q1 22.5M $3.71B +$70.6M $164.96 229
2022 Q4 22.3M $3.51B +$39.6M $157.48 239
2022 Q3 22.2M $3.34B -$250M $150.60 224
2022 Q2 21.4M $3.51B +$83.7M $164.39 240
2022 Q1 20.1M $4.48B +$167M $222.64 276
2021 Q4 20.2M $4.79B +$34.9M $237.34 285
2021 Q3 20M $4.66B -$54M $233.38 270
2021 Q2 20.3M $4.18B +$45.9M $205.80 265
2021 Q1 20M $4.11B +$108M $205.44 276
2020 Q4 19.4M $4.16B +$42M $214.49 268
2020 Q3 19.2M $3.51B -$32.2M $182.76 264
2020 Q2 19.4M $3.57B +$14.8M $184.31 275
2020 Q1 18.7M $3.77B -$39M $201.77 252
2019 Q4 19.6M $3.66B +$109M $187.12 256
2019 Q3 19.2M $3.06B -$159M $159.60 242
2019 Q2 19.5M $4.9B +$282M $251.91 262
2019 Q1 18.7M $4.48B -$78.1M $239.33 282
2018 Q4 19M $4.37B +$711M $229.63 283
2018 Q3 15.7M $4.44B +$195M $282.75 343
2018 Q2 15.1M $4.42B +$113M $293.65 338
2018 Q1 14.9M $3.75B -$171M $252.40 284
2017 Q4 15.6M $3.36B -$74.4M $216.00 252
2017 Q3 15.9M $2.95B +$33.8M $185.85 223
2017 Q2 15.7M $2.7B +$283M $172.50 223
2017 Q1 15.5M $2.37B +$296M $152.70 226
2016 Q4 15M $2.21B +$105M $147.35 241
2016 Q3 14.3M $1.81B +$26.1M $126.38 224
2016 Q2 14.3M $1.61B -$1.7M $112.75 212
2016 Q1 14.2M $1.48B +$24.4M $104.10 208
2015 Q4 14M $1.57B -$22.4M $112.78 221
2015 Q3 14.3M $1.56B -$35.5M $109.50 203
2015 Q2 14.5M $1.39B +$22.9M $95.66 192
2015 Q1 14.3M $1.33B +$32.3M $93.14 182
2014 Q4 14.2M $1.16B +$12.7M $81.90 192
2014 Q3 14.3M $917M -$3.37M $64.18 170
2014 Q2 14.3M $872M +$2.57M $60.81 159
2014 Q1 14M $836M +$39M $59.88 165